SriniVas R. Sadda, MD, and Alfredo A. Sadun, MD, PhD, Named to Los Angeles Business Journal’s Top Doctors 2024 List
Each year, the Los Angeles Business Journal Top Doctors in Los Angeles list shines a spotlight on the local doctors who help our community live healthier through providing outstanding health care and also those who conduct critical research. We are proud to share that two Doheny Eye Institute clinician scientists have been named to the 2024 Top Doctors list: Dr. SriniVas R. Sadda and Dr. Alfredo A. Sadun.
Dr. Sadda is the director of artificial intelligence and imaging research at Doheny, and professor of ophthalmology at the UCLA Geffen School of Medicine. His major research interests include retinal image analysis, advanced retinal imaging technologies, and clinical trial endpoint design, and he remains among the world’s foremost experts on the retina. He has more than 700 peer-reviewed publications and 20 book chapters and has given over 450 presentations worldwide. Dr. Sadda’s research has been continuously funded by the National Institutes of Health for several years, including a current R01 grant from the National Eye Institute. He was also recently named president of the Macula Society, and currently serves as president-elect of the Association for Research in Vision and Ophthalmology (ARVO).
Dr. Sadun is a world-renowned expert in ophthalmology who has made significant contributions to his field by using both his MD and PhD training. Dr. Sadun’s research has centered on the clinical, psychophysical and laboratory studies of diseases of the optic nerve. He has led pioneering efforts to help create the new science of mitochondrial ophthalmology, changing the way many optic neuropathies are now treated. In the 1980s, Dr. Sadun was the first to describe the nine anatomical pathways between the eye and the brain in humans including the retinal projection to the hypothalamus for the visual entrainment of the circadian rhythm.
Please join us in congratulating Dr. Sadda and Dr. Sadun for this prestigious recognition. It is yet another testament to the important, and outstanding, work that our internationally-renowned researchers do each day at Doheny.